Chemotherapy of advanced transitional cell carcinoma of the uroepithelium Frank M. TortiW. Graydon Harker Transitional Cell, Carcinoma, Chemotherapy Pages: S1 - S4
Intravesical chemotherapy in the United States Joseph T. Spaulding Intravesical Chemotherapy, United States Pages: S5 - S8
Phase-II trials in patients with urothelial tract tumors Alan Yagoda Phase-II Trial, Urothelial Cancer Pages: S9 - S12
Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project Gilbert H. Fiedell Bladder Cancer, Chemotherapy Pages: S13 - S15
Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors Michele Pavone-MacalusoMaria TripiGiovan Battista Ingargiola Bladder Cancer, Chemoprophylaxis Pages: S16 - S21
Intravesical instillation therapy with Adriamycin for bladder cancer in the Korean study group S. K. KimH. J. AnJ. H. Cho Intravesical Adriamycin, Bladder Cancer Pages: S22 - S24
Cooperative studies of systemic chemotherapy P. H. SmithJ. A. ChildR. Sylvester Chemotherapy, Bladder Cancer Pages: S25 - S31
Early adjuvant Adriamycin in superficial bladder carcinoma C. C. SchulmanL. J. DenisP. Van Erps Adjuvant Adriamycin, Superficial Bladder Pages: S32 - S34
Treatment of carcinoma in situ of the bladder with doxorubicin (Adriamycin) Robin W. Glashan Adriamycin, In Situ Bladder Cancer Pages: S35 - S37
Combination chemotherapy including Adriamycin for advanced transitional cell carcinoma of the urinary tract Toshihiko KotakeMichiyuki UsamiYutaka Takasugi Chemotherapy, Advanced Urinary Cancer Pages: S38 - S42
Combination chemotherapy for advanced bladder cancer with adriamycin, cyclophosphamide, and 5-fluorouracil Kazuya TashiroToyohei MachidaYukihiko Ohishi 5-Fluorouracil Adriamycin, Cyclophosphamide, Bladder Cancer Pages: S43 - S46
Evaluation of multidisciplinary treatment of bladder cancer, especially in chemoimmunotherapy (ADM and OK-432) as a consolidation therapy Yoshizo NakagamiTatsuo MinowaHansui Chin Chemotherapy, Immunotherapy, Bladder Cancer Pages: S47 - S50
Long-term intra-arterial infusion chemotherapy with Adriamycin for advanced bladder cancer Shori KanohTomokazu UmeyamaRyuichi Kitagawa Intra-Arterial Adriamycin, Bladder Cancer Pages: S51 - S58
Intra-arterial Adriamycin chemotherapy for bladder cancer Takeshi UyamaShoosuke MoriwakiJiro Fujita Intra-Arterial Adriamycin, Bladder Cancer Pages: S59 - S63
Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats Mikinobu OhtaniShoji FukushimaTadao Niijima Chemotherapy, Intravesical Preneoplastic Bladder Lesion in Rats Pages: S64 - S66
Intravesical chemotherapy in urinary bladder cancer Folke EdsmyrLennart AndersonPier-Luigi Esposti Intravesical Chemotherapy, Adriamycin, Bladder Cancer Pages: S67 - S68
Intravesical Adriamycin chemotherapy in bladder cancer Yosuke MatsumuraYujiro OzakiOkayama Urological Cancer Collaborative Group (OUCCG) Intravesical Chemotherapy, Adriamycin, Bladder Cancer Pages: S69 - S73
Mechanisms of action of intravesical treatment Gerhard JakseFerdinand Hofstädter Intravesical Chemotherapy, Bladder Cancer, Blood Group Isoantigen Pages: S74 - S78
Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer Tadao NiijimaKenkichi KoisoThe Japanese Urological Cancer Research Group for Adriamycin Superficial Bladder Cancer, Chemotherapy Pages: S79 - S82
Minimization of inflammation in the treatment of bladder tumors by intravesical instillation of Adriamycin Yoshitada OhiKenichiro OkamotoShizuo Yagi Bladder Cancer, Adriamycin Pages: S83 - S88
Development and clinical application of an AFC regimen (Adriamycin, Futraful, Cytosine arabinoside) for superficial bladder tumors Teruo MishinaTokuro KobayashiShuichi Nakagawa Adriamycin, Futraful, Ara-C, Bladder Cancer Pages: S89 - S90
Bladder instillation of Adriamycin in the treatment of bladder cancer Chun-Hsiung HuangChin-Pei Chiang Intravesical Adriamycin, Bladder Cancer Pages: S91 - S93
